Literature DB >> 12645735

Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease.

Jason A Petrofski1, Charles W Hoopes, Thomas M Bashore, Stuart D Russell, Carmelo A Milano.   

Abstract

Severely elevated pulmonary vascular resistance (PVR) is a relative contraindication to orthotopic heart transplantation. A potential novel strategy to reverse elevated PVR may be implantation of a chronic left ventricular assist device with subsequent left ventricular unloading. We present a patient with elevated PVR secondary to congenital heart disease who was listed for heart-lung transplant. The patient underwent placement of biventricular assist devices and subsequently experienced marked reduction of PVR, ultimately enabling successful heart transplantation.

Entities:  

Mesh:

Year:  2003        PMID: 12645735     DOI: 10.1016/s0003-4975(02)04372-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Durable mechanical circulatory support in teenagers and adults with congenital heart disease: A systematic review.

Authors:  Jill M Steiner; Eric V Krieger; Karen K Stout; April Stempien-Otero; Claudius Mahr; Nahush A Mokadam; Joshua L Hermsen
Journal:  Int J Cardiol       Date:  2017-08-02       Impact factor: 4.164

2.  Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Manveen K Gupta; Elizabeth E Martelli; Afshan K Hussain; Yilu Qin; Unni M Chandrasekharan; David Young; Arthur M Feldman; Subha Sen; Gerald W Dorn; Paul E Dicorleto; Sathyamangla V Naga Prasad
Journal:  Circulation       Date:  2013-06-19       Impact factor: 29.690

Review 3.  Impact of pulmonary vascular resistances in heart transplantation for congenital heart disease.

Authors:  Avihu Z Gazit; Charles E Canter
Journal:  Curr Cardiol Rev       Date:  2011-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.